Latest Breaking News On - Abbvie golden ticket - Page 1 : comparemela.com

/PRNewswire/ ResVita Bio, a synthetic biology startup, announces that it has been awarded a $250,000 Phase 1 Small Business Innovation Research (SBIR) grant.

United statesAmin zargarResvita bioNational institute of allergySmall business innovation researchBusiness innovation researchNational instituteInfectious diseaseChief executive officerNetherton syndromeRare pediatric disease designationVita bioBakar innovation fellowshipAbbvie golden ticket